TheraLight received clearance from the U.S. Food and Drug Administrationto market its UV120-2 UVA/UUVB Phototherapy System for the treatment ofpsoriasis, vitiligo, atopic dermatitis and seborrheic dermatitis.
The Weekly Roundup: March 20-24
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Highlights from AAD 2023
Vitamin D Supplements During Pregnancy May Reduce Eczema in Infants